- Free from Publisher J Pickup, H Keen - Diabetes care, 2002 - Am Diabetes Assoc Continuous subcutaneous insulin infusion (CSII) is used in selected type 1
diabetic subjects to achieve strict blood glucose control. A quarter of a
century after its introduction, world-wide use of CSII is increasing. We ... Cited by 224 - Related articles - BL Direct - All 8 versions
D Ketoacidosis - members.medscape.com Clinical guidelines are the first step in making standards of care explicit. Do
we need evidence-based consensus guidelines on the indications for a trial of
CSII? It might be argued that we do not. Some countries such as the US ... Related articles
D Ketoacidosis - members.medscape.com Patients with severely brittle diabetes (in the sense of a diabetes-disrupted
lifestyle with much time off from work or school and multiple admissions to
hospital) who suffer from recurrent ketoacidosis and apparent insulin ... Related articles
D Ketoacidosis - members.medscape.com At least 13 randomized controlled trials have compared CSII with intensified
insulin injection regimens [9-11,24-33] and have shown similar mean blood
glucose concentrations and glycated hemoglobin percentages in some studies ... Related articles
D Ketoacidosis - members.medscape.com The evidence base suggests that the expanding use of CSII is justified. The
unwillingness to fund pump therapy in some countries arises in part from the
erroneous belief that it is indicated for a large proportion of type 1 ... Related articles
D Ketoacidosis - members.medscape.com A few early studies indicated a high rate of ketoacidosis with CSII at some
centers [48,49] , and some physicians still consider this a serious side effect
of CSII [22] . But as patients and doctors became more experienced with the ... Related articles
D Ketoacidosis - members.medscape.com The notion that pump therapy is associated with severe hypoglycemia might have
arisen from early case reports of episodes of hypoglycemic coma during CSII [40]
and the fact that the DCCT [36] found that the rate of severe hypoglycemia ... Related articles
D Ketoacidosis - members.medscape.com A marked rise in the blood glucose concentration before breakfast occurs in many
injection-treated type 1 diabetic patients. It has come to be known as the "dawn
phenomenon" [53] and is due to a combination of waning of plasma insulin ... Related articles
C TRIALS, C GLYCEMIC, V INTENSIVE, I … - Diabetes Care, 2002 - Am Diabetes Assoc Continuous subcutaneous insulin infusion (CSII) is used in selected type 1
diabetic subjects to achieve strict blood glucose control. A quarter of a
century after its introduction, world-wide use of CSII is increasing. We ... Related articles - All 2 versions
- ►angrylapdog.com J Weissberg-Benchell, J Antisdel-Lomaglio, R … - Diabetes Care, 2003 - care.diabetesjournals.org.p.angrylapdog.com RESEARCH DESIGN AND METHODS—Studies were identified and data regarding study
design, year of publication, sample size, patient's age, diabetes duration, and
duration of CSII therapy were collected. Means and SDs for glycohemoglobin, ... Cited by 294 - Related articles - BL Direct - All 14 versions
